Leonard L. Mazur - Mar 21, 2022 Form 4 Insider Report for Hillstream BioPharma Inc. (HILS)

Role
Director
Signature
/s/ Randy Milby as Attorney-In-Fact for Leonard Mazur
Stock symbol
HILS
Transactions as of
Mar 21, 2022
Transactions value $
$0
Form type
4
Date filed
3/23/2022, 04:15 PM
Previous filing
Jan 18, 2022
Next filing
Nov 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HILS Options (right to buy) Award $0 +50K $0.00 50K Mar 21, 2022 Common stock 50K $1.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 21, 2022, the Reporting Person was granted options ("Options") to purchase up to 50,000 shares of the Registrant's common stock pursuant to the Registrant's 2019 Stock Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant.